ENTRY       D00902                      Drug
NAME        Zanamivir (USP/INN);
            Relenza (TN)
PRODUCT     RELENZA (GlaxoSmithKline LLC)
FORMULA     C12H20N4O7
EXACT_MASS  332.1332
MOL_WEIGHT  332.3098
CLASS       Antiviral
             DG03029  Anti-influenza virus agent
              DG02842  Neuraminidase inhibitor
REMARK      Same as: C08095
            ATC code: J05AH01
            Chemical structure group: DG00664
            Product (DG00664): D00902<US> D01937<JP>
EFFICACY    Antiviral, Neuraminidase inhibitor
  DISEASE   Influenza [DS:H00398]
TARGET      Influenza A/B virus neuraminidase [KO:K19392]
  PATHWAY   ko03230(K19392)  Viral genome structure
            ko05164(K19392)  Influenza A
STR_MAP     map07044  Antiviral agents
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             J ANTIINFECTIVES FOR SYSTEMIC USE
              J05 ANTIVIRALS FOR SYSTEMIC USE
               J05A DIRECT ACTING ANTIVIRALS
                J05AH Neuraminidase inhibitors
                 J05AH01 Zanamivir
                  D00902  Zanamivir (USP/INN) &lt;US&gt;
            USP drug classification [BR:br08302]
             Antivirals
              Anti-influenza Agents
               Zanamivir
                D00902  Zanamivir (USP/INN)
            Drug groups [BR:br08330]
             Antiviral
              DG03029  Anti-influenza virus agent
               DG02842  Neuraminidase inhibitor
                DG00664  Zanamivir
                 D00902  Zanamivir
            Drug classes [BR:br08332]
             Antiviral
              DG03029  Anti-influenza virus agent
               D00902  Zanamivir
            Antimicrobials [BR:br08307]
             Antivirals
              Virus release inhibitor
               Neuraminidase inhibitor
                D00902  Zanamivir (USP/INN) &lt;US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D00902
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D00902
            Drug groups [BR:br08330]
             Antiviral
              DG03029  Anti-influenza virus agent
               DG02842  Neuraminidase inhibitor
                DG00664  Zanamivir
            Antimicrobials abbreviations [BR:br08327]
             Antivirals
              Virus release inhibitor
               Neuraminidase inhibitor
                DG00664  Zanamivir
DBLINKS     CAS: 139110-80-8
            PubChem: 7847966
            ChEBI: 50663
            PDB-CCD: ZMR
            LigandBox: D00902
            NIKKAJI: J621.505J J680.760G
ATOM        23
            1   C2x C    23.0207  -17.2968
            2   C1y C    23.0207  -18.6980
            3   C1y C    24.2381  -19.4020
            4   C1y C    25.4412  -18.6980
            5   O2x O    25.4412  -17.2968
            6   C2y C    24.2381  -16.5997
            7   N1b N    21.8098  -19.4020
            8   C2c C    20.5986  -18.6980
            9   N1a N    19.3875  -19.4020
            10  N2a N    20.5986  -17.2968
            11  C6a C    24.2397  -15.1985
            12  O6a O    25.4480  -14.4960
            13  O6a O    23.0261  -14.4930
            14  N1b N    24.2397  -21.2232
            15  C5a C    23.0261  -21.9218
            16  C1a C    23.0280  -23.3230
            17  C1c C    26.6469  -19.3949
            18  C1c C    27.8579  -18.6909
            19  C1b C    29.0690  -19.3878
            20  O1a O    30.2801  -18.6838
            21  O1a O    27.8548  -17.2897
            22  O1a O    26.6486  -20.7961
            23  O5a O    21.8111  -21.2262
BOND        23
            1    11  12 1
            2     5   6 1
            3    11  13 2
            4     6   1 2
            5     3  14 1 #Down
            6    14  15 1
            7     2   7 1 #Up
            8    15  16 1
            9     7   8 1
            10    4  17 1
            11    1   2 1
            12   17  18 1
            13    8   9 1
            14   18  19 1
            15    2   3 1
            16   19  20 1
            17    8  10 2
            18   18  21 1 #Down
            19    3   4 1
            20   17  22 1 #Up
            21    6  11 1
            22   15  23 2
            23    4   5 1
///
